• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德国乳腺癌筛查的效果与成本预测。

Prediction of the effects and costs of breast-cancer screening in Germany.

作者信息

Beemsterboer P M, de Koning H J, Warmerdam P G, Boer R, Swart E, Dierks M L, Robra B P

机构信息

Department of Public Health, Erasmus Universiteit, Rotterdam, The Netherlands.

出版信息

Int J Cancer. 1994 Sep 1;58(5):623-8. doi: 10.1002/ijc.2910580502.

DOI:10.1002/ijc.2910580502
PMID:8077045
Abstract

Although breast-cancer screening programmes are now being introduced it is still debated whether this is an appropriate policy for all European countries. Taking into account empirical data from 2 regional pilot screening projects, this study has evaluated the effects and costs of a nationwide breast-cancer screening programme in Germany. Special attention was paid to the decentralized German health-care system and to the influence of attendance, interval and age group. The recent results of the analysis of the Swedish randomized screening trials were used to estimate the improvement in prognosis after early detection of breast cancer. Our analysis shows that a programme providing for the screening of women aged 50-69 at 2-year intervals might be expected to result in a decrease in mortality from breast cancer estimated at 11% for the total German population, representing 2,100 deaths from breast cancer prevented each year. The cost per life-year gained was assessed at between DM 18,800 and DM 25,300 for this scenario; 2 to 3 times less favourable than in the UK and The Netherlands. The sensitivity of mammography was estimated to be 12% lower than in The Netherlands and the attendance rate was calculated at 47% on average. A greater effort to ensure the quality of the screening programme and to improve the invitation system might finally lead to much better results. The mortality reduction might be as much as 18% if the attendance and the sensitivity of the screening could be improved to the Dutch level.

摘要

尽管目前正在推行乳腺癌筛查项目,但对于这是否适用于所有欧洲国家仍存在争议。考虑到两个地区试点筛查项目的实证数据,本研究评估了德国全国性乳腺癌筛查项目的效果和成本。特别关注了德国分散的医疗保健系统以及参与率、筛查间隔和年龄组的影响。利用瑞典随机筛查试验的最新分析结果来估计乳腺癌早期发现后预后的改善情况。我们的分析表明,一个为50至69岁女性每两年进行一次筛查的项目,预计可能会使德国总人口的乳腺癌死亡率降低11%,即每年可预防2100例乳腺癌死亡。在这种情况下,每获得一个生命年的成本估计在18,800德国马克至25,300德国马克之间;比英国和荷兰的情况差2至3倍。乳房X线摄影的敏感度估计比荷兰低12%,平均参与率计算为47%。加大力度确保筛查项目的质量并改进邀请系统,最终可能会带来更好的结果。如果参与率和筛查敏感度能够提高到荷兰的水平,死亡率降低幅度可能高达18%。

相似文献

1
Prediction of the effects and costs of breast-cancer screening in Germany.德国乳腺癌筛查的效果与成本预测。
Int J Cancer. 1994 Sep 1;58(5):623-8. doi: 10.1002/ijc.2910580502.
2
Quantitative estimates of the impact of sensitivity and specificity in mammographic screening in Germany.德国乳腺钼靶筛查中敏感度和特异度影响的定量估计。
J Epidemiol Community Health. 1997 Apr;51(2):180-6. doi: 10.1136/jech.51.2.180.
3
Breast cancer screening; cost-effective in practice?乳腺癌筛查;在实际中具有成本效益吗?
Eur J Radiol. 2000 Jan;33(1):32-7. doi: 10.1016/s0720-048x(99)00105-9.
4
5
Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.北欧国家癌症筛查对截至2017年的死亡、成本和生活质量的影响。
Acta Oncol. 1997;36 Suppl 9:1-60.
6
Radiation risk of mammography related to benefit in screening programmes: a favourable balance?乳腺钼靶摄影的辐射风险与筛查项目中的获益相关:利弊平衡是否有利?
J Med Screen. 1998;5(2):81-7. doi: 10.1136/jms.5.2.81.
7
Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.瑞典乳腺癌筛查试验中特定年龄死亡率降低的定量解读。
J Natl Cancer Inst. 1995 Aug 16;87(16):1217-23. doi: 10.1093/jnci/87.16.1217.
8
Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors.乳腺癌筛查与成本效益;政策选择、生活质量考量以及不确定因素的可能影响。
Int J Cancer. 1991 Oct 21;49(4):531-7. doi: 10.1002/ijc.2910490410.
9
Dutch digital breast cancer screening: implications for breast cancer care.荷兰数字式乳腺癌筛查:对乳腺癌护理的影响。
Eur J Public Health. 2012 Dec;22(6):925-9. doi: 10.1093/eurpub/ckr170. Epub 2011 Dec 8.
10
Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.家族性乳腺癌风险女性的磁共振成像筛查的成本效益。
J Natl Cancer Inst. 2013 Sep 4;105(17):1314-21. doi: 10.1093/jnci/djt203. Epub 2013 Aug 12.

引用本文的文献

1
Evaluation of skin cancer screening in Germany - a Microsimulation.德国皮肤癌筛查评估——微观模拟
J Dtsch Dermatol Ges. 2025 Jan;23(1):19-27. doi: 10.1111/ddg.15539. Epub 2024 Nov 9.
2
Breast cancer in European Union: an update of screening programmes as of March 2014 (review).欧盟的乳腺癌:截至 2014 年 3 月的筛查项目更新(综述)。
Int J Oncol. 2014 Nov;45(5):1785-92. doi: 10.3892/ijo.2014.2632. Epub 2014 Sep 1.
3
Cost effectiveness of breast cancer screening using mammography; a systematic review.使用乳房X线摄影术进行乳腺癌筛查的成本效益;一项系统评价。
Iran J Public Health. 2013 Apr 1;42(4):347-57. Print 2013.
4
Cost-effectiveness analysis of screening modalities for breast cancer in Japan with special reference to women aged 40-49 years.日本乳腺癌筛查方式的成本效益分析——特别关注40至49岁女性
Cancer Sci. 2006 Nov;97(11):1242-7. doi: 10.1111/j.1349-7006.2006.00296.x. Epub 2006 Aug 17.
5
Investing in early detection versus intensive treatment for breast cancer: a study of the Israeli public priorities.乳腺癌早期检测与强化治疗的投资:一项关于以色列公众优先事项的研究。
Health Expect. 1999 Sep;2(3):179-184. doi: 10.1046/j.1369-6513.1999.00051.x.
6
Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study.缩短英国国家医疗服务体系乳房筛查项目的筛查间隔或扩大年龄范围的成本效益:计算机模拟研究
BMJ. 1998 Aug 8;317(7155):376-9. doi: 10.1136/bmj.317.7155.376.
7
Quantitative estimates of sensitivity and specificity in mammographic screening.乳腺钼靶筛查中敏感性和特异性的定量评估。
J Epidemiol Community Health. 1997 Dec;51(6):731. doi: 10.1136/jech.51.6.731.
8
Quantitative estimates of the impact of sensitivity and specificity in mammographic screening in Germany.德国乳腺钼靶筛查中敏感度和特异度影响的定量估计。
J Epidemiol Community Health. 1997 Apr;51(2):180-6. doi: 10.1136/jech.51.2.180.
9
Changes in use of breast-conserving therapy in years 1978-2000.1978年至2000年保乳治疗的使用变化。
Br J Cancer. 1994 Dec;70(6):1165-70. doi: 10.1038/bjc.1994.466.